{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:22:04Z","timestamp":1786998124314,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021954","name":"Tour de Cure","doi-asserted-by":"publisher","award":["RSP-120-2025"],"award-info":[{"award-number":["RSP-120-2025"]}],"id":[{"id":"10.13039\/501100021954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP177524"],"award-info":[{"award-number":["APP177524"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Genetics and Genomics Advances"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xhgg.2025.100484","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:55:59Z","timestamp":1753116959000},"page":"100484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1970-9912","authenticated-orcid":false,"given":"Cristina","family":"Fortuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy E.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Pesaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McGoldrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-7897","authenticated-orcid":false,"given":"Amanda B.","family":"Spurdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xhgg.2025.100484_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100484_bib2","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","article-title":"Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel","volume":"111","author":"Parsons","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xhgg.2025.100484_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/jmg-2022-108807","article-title":"Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines","volume":"60","author":"Luo","year":"2023","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.xhgg.2025.100484_bib4","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/humu.23636","article-title":"Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel","volume":"39","author":"Mester","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2025.100484_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/humu.24152","article-title":"Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants","volume":"42","author":"Fortuno","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2025.100484_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101305","article-title":"Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)","volume":"27","author":"Garrett","year":"2025","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100484_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xhgg.2025.100484_bib8","article-title":"Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum","volume":"8","author":"Fortuno","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/jcm13051223","article-title":"Whole-Body MRI Screening for Carriers of Germline TP53 Mutations-A Systematic Review and Meta-Analysis","volume":"13","author":"Temperley","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.xhgg.2025.100484_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib11","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xhgg.2025.100484_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","article-title":"Mutational processes shape the landscape of TP53 mutations in human cancer","volume":"50","author":"Giacomelli","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xhgg.2025.100484_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molcel.2018.06.012","article-title":"A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation","volume":"71","author":"Kotler","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xhgg.2025.100484_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","article-title":"Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations","volume":"57","author":"Funk","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xhgg.2025.100484_bib15","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib16","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"de Andrade","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib18","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1002\/cncr.33143","article-title":"What 20 years of research has taught us about the TP53 p.R337H mutation","volume":"126","author":"Pinto","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.xhgg.2025.100484_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jmedgenet-2017-104560","article-title":"The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium","volume":"55","author":"Moghadasi","year":"2018","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.xhgg.2025.100484_bib20","article-title":"Personalized screening strategies for TP53 R337H carriers: a retrospective cohort study of tumor spectrum in Li-Fraumeni syndrome adult carriers","volume":"42","author":"Galante","year":"2025","journal-title":"Lancet Reg. Health. Am."},{"key":"10.1016\/j.xhgg.2025.100484_bib21","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xhgg.2025.100484_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111296","article-title":"Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome","volume":"27","author":"Montellier","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.xhgg.2025.100484_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/humu.23158","article-title":"PERCH: A Unified Framework for Disease Gene Prioritization","volume":"38","author":"Feng","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2025.100484_bib24","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/humu.20896","article-title":"Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications","volume":"29","author":"Tavtigian","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2025.100484_bib25","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/humu.23553","article-title":"Improved, ACMG-Compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants","volume":"39","author":"Fortuno","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2025.100484_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xhgg.2025.100484_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41586-022-04696-z","article-title":"Fundamental immune-oncogenicity trade-offs define driver mutation fitness","volume":"606","author":"Hoyos","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xhgg.2025.100484_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xhgg.2025.100484_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/hmg\/ddae009","article-title":"Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG\/AMP guidelines","volume":"33","author":"Fortuno","year":"2024","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xhgg.2025.100484_bib30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.gim.2021.10.018","article-title":"Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicity","volume":"24","author":"Fortuno","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100484_bib31","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib32","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1200\/JCO.2022.40.16_suppl.10612","article-title":"Questioning a Li-Fraumeni Syndrome diagnosis: Characterization of a commonly observed germline TP53 variant Arg156His","volume":"40","author":"Nehoray","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xhgg.2025.100484_bib33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/1078-0432.CCR-24-3301","article-title":"Update on Cancer Screening Recommendations for Individuals with Li\u2013Fraumeni Syndrome","volume":"31","author":"Achatz","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xhgg.2025.100484_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaf008","article-title":"Cancer risk in carriers of TP53 germline variants grouped into different functional categories","volume":"9","author":"M\u00fcntnich","year":"2025","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.xhgg.2025.100484_bib35","article-title":"Combining multiplexed functional data to improve variant classification","author":"Calhoun","year":"2025","journal-title":"arXiv"}],"container-title":["Human Genetics and Genomics Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247725000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247725000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T20:32:16Z","timestamp":1765398736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666247725000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666247725000879"],"URL":"https:\/\/doi.org\/10.1016\/j.xhgg.2025.100484","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.06.652567","asserted-by":"object"}]},"ISSN":["2666-2477"],"issn-type":[{"value":"2666-2477","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53","name":"articletitle","label":"Article Title"},{"value":"Human Genetics and Genomics Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xhgg.2025.100484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society of Human Genetics.","name":"copyright","label":"Copyright"}],"article-number":"100484"}}